Fred Alger Management’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-35,447
| Closed | -$139K | – | 538 |
|
|
2019
Q3 | $139K | Hold |
35,447
| – | – | ﹤0.01% | 405 |
|
|
2019
Q2 | $527K | Sell |
35,447
-54,964
| -61% | -$993K | ﹤0.01% | 376 |
|
|
2019
Q1 | $2.24M | Buy |
90,411
+12,115
| +15% | +$304K | 0.01% | 278 |
|
|
2018
Q4 | $1.41M | Buy |
78,296
+7,218
| +10% | +$147K | 0.01% | 297 |
|
|
2018
Q3 | $2.09M | Sell |
71,078
-101,278
| -59% | -$3.92M | 0.01% | 283 |
|
|
2018
Q2 | $7.84M | Buy |
172,356
+51,054
| +42% | +$2.48M | 0.03% | 191 |
|
|
2018
Q1 | $6.41M | Sell |
121,302
-521,407
| -81% | -$30.4M | 0.03% | 205 |
|
|
2017
Q4 | $43.7M | Sell |
642,709
-185,698
| -22% | -$13M | 0.2% | 97 |
|
|
2017
Q3 | $68.3M | Buy |
828,407
+270,727
| +49% | +$21.5M | 0.32% | 75 |
|
|
2017
Q2 | $52.2M | Buy |
557,680
+390,645
| +234% | +$23.9M | 0.25% | 85 |
|
|
2017
Q1 | $10.6M | Buy |
167,035
+97,527
| +140% | +$5.93M | 0.05% | 169 |
|
|
2016
Q4 | $3.09M | Buy |
69,508
+50,508
| +266% | +$1.78M | 0.02% | 225 |
|
|
2016
Q3 | $685K | Buy |
+19,000
| New | +$408K | ﹤0.01% | 337 |
|
|
2015
Q4 | – | Sell |
-104,991
| Closed | -$9.65M | – | 602 |
|
|
2015
Q3 | $9.65M | Sell |
104,991
-31,033
| -23% | -$2.69M | 0.05% | 190 |
|
|
2015
Q2 | $12M | Sell |
136,024
-18,095
| -12% | -$1.55M | 0.05% | 208 |
|
|
2015
Q1 | $11.4M | Buy |
154,119
+153,514
| +25,374% | +$10.8M | 0.05% | 246 |
|
|
2014
Q4 | $34K | Hold |
605
| – | – | ﹤0.01% | 496 |
|
|
2014
Q3 | $27K | Hold |
605
| – | – | ﹤0.01% | 510 |
|
|
2014
Q2 | $25K | Hold |
605
| – | – | ﹤0.01% | 524 |
|
|
2014
Q1 | $42K | Buy |
605
+15
| +3% | +$1.1K | ﹤0.01% | 484 |
|
|
2013
Q4 | $36K | Hold |
590
| – | – | ﹤0.01% | 469 |
|
|
2013
Q3 | $36K | Buy |
+590
| New | +$41.8K | ﹤0.01% | 474 |
|
Other funds holding CLVS
PAI
AG
CS
PA